# China NMPA Drug Inspection - Guangdong Bidi Pharmaceutical Co., Ltd. - Amoxicillin granules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/guangdong-bidi-pharmaceutical-co-ltd/13fbd1d1-1564-4fd9-bc4e-c01ce4d43db1/
Source feed: China

> China NMPA drug inspection for Guangdong Bidi Pharmaceutical Co., Ltd. published November 11, 2021. Drug: Amoxicillin granules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Information Bulletin on Drug Quality Sampling Inspection in Qinghai Province (Issue 2, 2021)
- Company Name: Guangdong Bidi Pharmaceutical Co., Ltd.
- Publication Date: 2021-11-11
- Drug Name: Amoxicillin granules
- Inspection Finding: qualified

Company: https://www.globalkeysolutions.net/companies/guangdong-bidi-pharmaceutical-co-ltd/9e579f82-a219-49c9-ba98-ac135c1c6832/